WuXi Biologics CEO Says China to Be Next Frontier for Industry

The transcript discusses the growth of China's biologic market, highlighting Wuxi Biologics' role in pharmaceutical innovation. It addresses quality concerns, global standards, and the company's market advantages, including a large talent pool. The expansion plans in Ireland, Singapore, and the US aim to strengthen customer relationships. The focus on R&D and a diverse drug pipeline, including oncology and CNS diseases, is emphasized. The future of cancer treatment, particularly immuno-oncology and gene therapy, is explored, with hopes of turning cancer into a chronic disease.

What is the significance of the company's investment in R&D compared to others in the service industry?

What are the most exciting areas of research and development mentioned in the text?

In the speaker's opinion, will there ever be a cure for cancer, and what factors contribute to this belief?